article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants).

article thumbnail

For Some Platforms, Network Effects Are No Match for Local Know-How

Harvard Business Review

Uber’s setback in the international market, however, wasn’t its first. To venture capitalists and the financial market, no business model is more attractive than a platform. Any platform still needs to achieve a product-market fit to succeed in the long run.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. No 20,000 tech jobs. I know many smart investors didn't.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. No 20,000 tech jobs. I know many smart investors didn't.

article thumbnail

Case Study: Should an Emerging-Market Incubator Help U.S. Businesses?

Harvard Business Review

In fact, her love of the city’s mingled cultures and vibrant local businesses was one of the things that had inspired her to cofound Unamano, now a world-renowned nonprofit that supported entrepreneurship in emerging markets. Unamano’s mission was to help entrepreneurs in emerging markets—not in the United States.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies.

article thumbnail

Artificial Intelligence Is Almost Ready for Business

Harvard Business Review

AI is filling this gap as it becomes ingrained in the analytics technology infrastructure in industries like health care, financial services, and travel. Rather than take the cutting edge capabilities developed in its research labs to market as a series of products, IBM has chosen to offer a platform of services under the Watson brand.